（中・日・英語版）1_Announcement of NMPA on Direct Reporting of ADRs by Drug MHA (No. [2018] 66)_C_J_E.pdf 2022.06.28
（中・日・英語版）2_Guidelines for the Collection and Reporting of Individual Adverse Drug Reactions_C_J_E 2022.06.27
（中・日・英語版）3_Standards and Procedures for Expedited Reporting of Safety Data during Drug Clinical Trials_C_J_E 2022.06.26
ICH E2B(R3) Core Data Elements/ Regional Elements (FDA/NMPA/MFDS/EMA/PMDA) and Business Rules ver.7.00 (updated 6/Feb/2023) 2022.06.26
